Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03469505 · ClinicalTrials.gov registry record · NA

Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)

A NA study of Pain, Chronic, sponsored by Yale University.

Completed
Registry status
NA
Development phase
764
Enrollment target
9
Study locations

NCT03469505 is a NA study of Pain, Chronic that has completed, run by Yale University. The registered enrollment target is 764 participants, roughly in line with the 706-participant average among 48 other Pain, Chronic trials with a reported enrollment target. The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03469505, a NA study of Pain, Chronic, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
764 participants
Enrollment target
9
Study locations

Study Summary

To conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA) Cognitive Behavioral Therapy Chronic Pain (CBT-CP)

Conditions Studied

Interventions

  • BEHAVIORAL COPES
  • BEHAVIORAL CBT-CP

Study Locations (9)

Texas

  • VA North Texas Healthcare System - Dallas
  • VA Central Texas Healthcare System - Temple

Illinois

  • Edward Hines, Jr. VA Hospital - Hines

Massachusetts

  • VA Central Western Massachusetts - Leeds

Michigan

  • VA Ann Arbor Healthcare System - Ann Arbor

Mississippi

  • G.V. (Sonny) Montgomery VA Medical Center - Jackson

Oklahoma

  • Oklahoma City VA Health Care System - Oklahoma City

South Carolina

  • Ralph H. Johnson VA Medical Center - Charleston

Washington

  • VA Puget Sound Healthcare System - Seattle

Trial Details

FieldValue
Enrollment Target 764 participants
Start Date 2019-12-27
Est. Completion 2025-02-20
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT03469505

The ClinicalTrials.gov registry entry for NCT03469505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 764 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 706-participant average among 48 other Pain, Chronic trials with a reported enrollment target. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Chronic appearing as the primary indexed condition, and to 2 interventions - of which COPES is the first listed.

NCT03469505 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Texas, Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03469505 about?

NCT03469505 is a clinical study titled "Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)". To conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA) Cognitive Behavioral Therapy Chronic Pain (CBT-CP)

What is the current status of trial NCT03469505?

This trial is currently completed. It is a NA study. The enrollment target is 764 participants. The study started on 2019-12-27. Estimated completion is 2025-02-20.

What conditions does trial NCT03469505 study?

This clinical trial studies the following conditions: Pain, Chronic.

What interventions are being tested in trial NCT03469505?

The interventions under investigation include: COPES (BEHAVIORAL), CBT-CP (BEHAVIORAL).

Who is sponsoring clinical trial NCT03469505?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03469505 being conducted?

This trial has 9 study locations across Illinois, Massachusetts, Michigan, Mississippi, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.